Fundraising Fox

Etheros Pharmaceuticals

Nashville, US · Founded 2022 · Delaware corporation

Biotech

Founders & leadership

SC
Subhasish ChakrabortyExecutive
JW
John William ScannellExecutive
FK
Francis KnuettelNamed on SEC filing

Board

MF
Marc FeldmannBoard director
FK
Francis Knuettel IIBoard director
LD
Laura DuganBoard director

Reported raises · per SEC filings

Form D private placements

$1.7M disclosed across 3 rounds · 2023–2025

▶$600KraisedJun 2025 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Subhasish ChakrabortyExecutive Officer
  • John William ScannellExecutive Officer, Director
  • Marc FeldmannDirector
  • Francis Knuettel IIDirector
  • Laura DuganDirector
Offering amount
$600K
Amount sold
$600K
Minimum investment
$50K
Proceeds to insiders
$13K
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedDec 2023 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Subhasish ChakrabortyExecutive Officer
  • John William ScannellExecutive Officer, Director
  • Francis KnuettelDirector
  • Marc FeldmannDirector
  • Laura DuganDirector
Offering amount
$300K
Amount sold
$300K
Minimum investment
$60K
First sale
Nov 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$775KraisedDec 2023 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Subhasish ChakrabortyExecutive Officer
  • John William ScannellExecutive Officer, Director
  • Laura DuganDirector
  • Marc FeldmannDirector
  • Francis KnuettelDirector
Offering amount
$775K
Amount sold
$775K
Minimum investment
$25K
Proceeds to insiders
$350K
First sale
Feb 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Immortal Dragons Will Help Etheros Target Aging and Related Diseases | Pharmaceutical Technologypharmtech.com · Aug 2026Immortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidantsfinance.yahoo.com · Dec 2025Etheros Pharmaceuticals Corp. (CIK: 0002005132) EDGAR, Information, Filings... CompaniesBIO.Comcompaniesbio.com

Frequently asked questions

How much funding has Etheros Pharmaceuticals raised?
Etheros Pharmaceuticals has disclosed $1.7M raised across 3 rounds.
Where is Etheros Pharmaceuticals headquartered?
Etheros Pharmaceuticals is headquartered in Nashville, US.